Tnfa-Inhibition in the Treatment of Rheumatoid Arthritis - Couverture souple

Moreland, Larry W.; Emery, Paul

 
9781841841564: Tnfa-Inhibition in the Treatment of Rheumatoid Arthritis

Synopsis

The introduction of tumor-necrosis-factor-alpha (TNFa) blocking agents is one of the milestones in the therapy of rheumatoid arthritis (RA). Edited by Larry Moreland and Paul Emery, experts in rheumatological disease, TNFa-Inhibition in the Treatment of Rheumatoid Arthritis charts the history and development of the concept of TNFa inhibition. The authors document TNFa from its discovery to its now well-documented clinical applications in the treatment of patients with RA. They compare and contrast practical management issues concerning the use of these agents both in the US and UK/Europe. The book is a practical and accessible source containing the most recent information in this field.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Biographie de l'auteur

Jacob Boe is Professor, Department of Thoracic Medicine, Rikshospitalet, Oslo, Norway. He is Past-President of the ERS and Co-Chairman of the ERS Nebulizer Task Force.

B. Ronan O'Driscoll, BSc, MD, FRCP, is Consultant Respiratory Physician, Cardiorespiratory Medicine, Hope Hospital, Salford, UK. He is Co-Chairman of the ERS Nebulizer Task Force. He has published several papers on clinical uses of nebulized therapy.

John H. Dennis, PhD, MSc, BSc, MBIOH, DipOccHyg is a Senior Lecturer in Occupational Hygiene and Pollution Science, Department of Environmental Medicine, University of Bradford, Bradford, UK. He is Co-Chairman of the ERS Nebulizer Task Force.

Présentation de l'éditeur

The introduction of tumor-necrosis-factor-alpha (TNFa) blocking agents is one of the milestones in the therapy of rheumatoid arthritis (RA). Edited by Larry Moreland and Paul Emery, experts in rheumatological disease, TNFa-Inhibition in the Treatment of Rheumatoid Arthritis charts the history and development of the concept of TNFa inhibition. The authors document TNFa from its discovery to its now well-documented clinical applications in the treatment of patients with RA. They compare and contrast practical management issues concerning the use of these agents both in the US and UK/Europe. The book is a practical and accessible source containing the most recent information in this field.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Autres éditions populaires du même titre

9780203624388: Tnf-Inhibition in the Treatment of Rheumatoid Arthritis

Edition présentée

ISBN 10 :  0203624386 ISBN 13 :  9780203624388
Couverture rigide